ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESM..................*XJDIM360 Ver 1.28 (29 Oct 2014) - 1100000/02976071A120160127EP14716904.92014032120150814frfrfr135256920130322FR2016012720160420160127201604A61K 31/135 20060101AFI20141015BHEP A61K 31/165 20060101ALI20141015BHEP A61K 31/197 20060101ALI20141015BHEP A61K 31/381 20060101ALI20141015BHEP A61K 31/403 20060101ALI20141015BHEP A61K 45/06 20060101ALI20141015BHEP A61P 25/02 20060101ALI20141015BHEP A61P 25/04 20060101ALI20141015BHEP A61P 25/22 20060101ALI20141015BHEP A61P 25/24 20060101ALI20141015BHEP deVERWENDUNG VON 4-[3-[CIS-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL-]-PROPOXY}BENZAMID ZUR BEHANDLUNG NEUROPATHISCHER SCHMERZENenUSE OF 4-{3-[CIS-HEXAHYDROCYCLOPENTA[C]PYRROLE-2(1H)-YL]PROPOXY}BENZAMIDE FOR TREATING NEUROPATHIC PAINfrUTILISATION DU 4-{3-[CIS-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL]PROPOXY}BENZAMIDE POUR LE TRAITEMENT DES DOULEURS NEUROPATHIQUESLes Laboratoires Servier10155690538093-NeuroBrevets 35, rue de Verdun92284 SuresnesFRSORS, Aurore131 rue de JavelF-75015 ParisFRMERDES, AnnetteWessobrunner Strasse 2481377 MunichDEALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRBA20150814ME20150814FR201405065920140321frWO201414735320140925201439